NasdaqCM - Nasdaq Real Time Price USD

SAB Biotherapeutics, Inc. (SABSW)

0.0227
-0.0102
(-31.00%)
At close: May 19 at 4:00:00 PM EDT

Research Analysis

Revenue vs. Earnings

Revenue --
Earnings --

Q2'24

Q3'24

Q4'24

Q1'25

-10M
-8M
-6M
-4M
-2M
0
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 5555
Avg. Estimate 100k100k300k600k
Low Estimate --------
High Estimate 500k500k1.5M3M
Year Ago Sales 263.14k--1.32M300k
Sales Growth (year/est) -62.00%0.00%-77.31%100.00%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
SABSW --------
S&P 500 13.32%2.61%7.73%13.77%